Biogen Inc Balance Sheet Quarterly
BIIB
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
BIIB Balance Sheets
(Quarterly, GAAP in millions $) |
(Jun 30 2024) II. Quarter |
(Mar 31 2024) I. Quarter |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
ASSETS |
Cash & cash equivalent |
- |
- |
- |
- |
- |
Cash, Cash eqvivalents other |
- |
- |
- |
- |
- |
Available-for-sale Securities, Debt Securities, Current MA |
- |
- |
- |
- |
3,460.50 |
Cash
& Short-term Investments |
- |
- |
- |
- |
3,460.50 |
Accounts receivable |
1,627.10 |
1,604.50 |
1,664.10 |
1,781.40 |
1,685.90 |
Other receivables net |
- |
- |
- |
- |
- |
Net Receivables |
- |
- |
- |
- |
- |
Due From Unconsolidated Joint Business |
- |
- |
435.90 |
- |
- |
Inventories |
2,506.10 |
2,516.80 |
2,527.40 |
2,982.40 |
1,333.50 |
Other current assets |
2,975.30 |
2,634.90 |
2,667.80 |
3,690.30 |
3,951.80 |
Total Current Assets |
7,108.50 |
6,756.20 |
6,859.30 |
8,454.10 |
10,431.70 |
Equipment/Property/Plant Net |
3,249.30 |
3,275.30 |
3,309.70 |
3,301.60 |
3,307.20 |
Goodwill net |
6,227.40 |
6,227.40 |
6,219.20 |
6,807.50 |
5,753.70 |
Intangible Assets |
8,232.90 |
8,284.70 |
8,363.00 |
7,344.60 |
1,776.40 |
Long-term investments |
- |
- |
- |
0.10 |
1,208.00 |
Accounts Receivable, Net, Noncurrent |
- |
- |
- |
- |
- |
Restricted cash |
- |
- |
- |
- |
- |
Deferred Tax Assets, Net, Noncurrent AS |
- |
- |
- |
- |
- |
Other Assets |
1,599.00 |
1,597.00 |
1,674.00 |
1,827.00 |
2,315.00 |
Assets held for sale |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Operating Lease Right Of Use Asset |
389.40 |
428.10 |
420.00 |
460.90 |
366.50 |
Total Assets |
26,804.10 |
26,567.60 |
26,844.80 |
28,193.20 |
25,156.80 |
LIABILITIES |
Accounts Payable, Current AC |
354.50 |
387.00 |
403.30 |
440.10 |
445.40 |
Accrued liabilities |
- |
- |
- |
- |
- |
Restructuring liabilities |
- |
- |
- |
- |
- |
Notes Payable, Current NO |
- |
250.00 |
150.00 |
500.00 |
- |
Other current liabilities |
2,472.10 |
2,354.60 |
2,623.60 |
3,838.40 |
2,481.10 |
Taxes Payable, Current, Total |
281.60 |
231.20 |
257.40 |
243.80 |
260.00 |
Interest |
- |
- |
- |
- |
- |
Customer deposits |
- |
- |
- |
- |
- |
Total Current Liabilities |
3,108.20 |
3,222.80 |
3,434.30 |
5,022.30 |
3,186.50 |
Long-term debt |
6,292.00 |
6,290.10 |
6,788.20 |
6,786.40 |
6,284.60 |
Capital lease obligations |
- |
- |
- |
- |
- |
Long-term debt Convertible |
- |
- |
- |
- |
- |
Total
Long-term Debt |
6,292.00 |
6,290.10 |
6,788.20 |
6,786.40 |
6,284.60 |
Other Preferred stock |
- |
- |
- |
- |
- |
Employee benefit plans |
- |
- |
- |
- |
- |
Deferred rent |
- |
- |
- |
- |
- |
Deferred Tax Liabilities, Net, Noncurrent LI |
- |
- |
- |
- |
- |
Disposal Group, Including Discontinued Operation, Other Liabilities |
- |
- |
- |
- |
- |
Other longterm liabilities |
1,514.80 |
1,841.70 |
1,822.90 |
1,904.80 |
1,225.20 |
Operating Lease Liability Noncurrent |
367.50 |
406.50 |
400.00 |
428.80 |
304.40 |
Total Liabilities |
10,915.00 |
11,354.60 |
12,045.40 |
13,713.50 |
10,696.30 |
SHAREHOLDER'S EQUITY |
Common Stock Value |
0.10 |
0.10 |
0.10 |
0.10 |
0.10 |
Treasury Stock Value |
-2,977.10 |
-2,977.10 |
-2,977.10 |
-2,977.10 |
-2,977.10 |
Additional Paid In Capital Common Stock |
407.50 |
329.50 |
302.50 |
242.20 |
170.70 |
Retained Earnings / Accumulated Deficit |
18,604.60 |
18,021.00 |
17,627.60 |
17,377.90 |
17,446.00 |
Other Equity |
-146.00 |
-160.50 |
-154.10 |
-159.30 |
-172.80 |
Noncontrolling interests & other |
- |
- |
- |
-4.10 |
-6.40 |
Total
Stockholder's Equity |
15,889.10 |
15,213.00 |
14,799.40 |
14,479.70 |
14,460.50 |
Liabilities & Stockholder's
Equity |
26,804.10 |
26,567.60 |
26,844.80 |
28,193.20 |
25,156.80 |
|
|